Phase 2/3 Wave II Clinical Study to Begin in 2026 Completion of Financing to Support Registration Program MONTREAL, Sept. CNW ...

The Bank of England kept rates unchanged on Thursday and said it was slowing the pace of its quantitative tightening ...

The Bank of England will slow the pace at which it is reducing its government bond holdings and skew sales away from ...

The Bank of England’s decision to slow the pace and change the make-up of its quantitative tightening plan on Thursday ...

Gender-affirming hormone therapy had opposite effects on cardiac repolarization patterns among transgender men and transgender women.

The Bank of England left rates unchanged on Thursday and said it was slowing the pace of its quantitative tightening ...

The Bank of England's Huw Pill said the recent decision to slow its QT programme risked a "more painful" crisis in the future ...

Judging by interest rate market pricing, this week's BoE meeting should be one of the least interesting of the major central ...

The Bank of England (BOE) will likely keep rates on hold today, following a hawkish cut in August. Markets are also pricing ...

The Bank of England has come to a decision on interest rates amid high inflation, a weakened jobs market and pressure on ...

The Company has submitted a supplemental New Drug Application (sNDA) seeking the approval of revumenib for the treatment of R/R mNPM1 AML. The sNDA has been granted Priority Review by the FDA and ...